Innoviva (INVA) Financials: Revenue & Earnings

INVA price $21.04 +0.10 +0.48%

Ticker
INVA
Price
$21.04
Change
+0.10 +0.48%
Market cap ?
$1.52B
P/E ?
4.29
Forward P/E ?
8.69
Dividend yield ?
0.00%
Beta ?
0.33
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
70
Value
72
Quality
71
Growth
67

Stocklytics score rationale: value 72, quality 71, growth 67.

Financials

2016201720182019202020212022202320242025
133569000217217000261004000261016000336794000391866000331339000310463000358711000425128000

Innoviva, Inc. functions as a pharmaceutical company, concentrating on the worldwide creation and marketing of medical treatments. Its current product lineup prominently includes several once-daily combination therapies: RELVAR/BREO ELLIPTA, which integrates vilanterol (a long-acting beta2 agonist, or LABA) with fluticasone furoate (an inhaled corticosteroid, or ICS); ANORO ELLIPTA, a medication that pairs…

Fair value

INVA fair value $29.79. Price $21.04. Price is 29% below fair value.

Below fair value, but more expensive than usual. A smaller discount than on 80% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 188.32M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 72.25M. Net debt -281.92M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare INVA

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—0.52—115.31M
2026-08-051.140.44119.59M110.98M
2026-05-060.440.4397.99M101.57M
2026-02-251.940.34114.61M102.62M
2025-11-051.080.46107.80M91.36M
2025-08-060.770.57100.28M92.04M
2025-05-070.740.2988.63M82.67M
2025-02-260.260.3491.81M86.80M
2024-11-060.020.2789.51M76.91M
2024-07-31-0.550.2499.90M74.69M
2024-05-080.460.1777.50M68.00M
2024-03-010.760.2385.84M75.52M
2023-11-010.980.2767.26M75.66M
2023-08-020.020.2680.99M67.92M
2023-04-260.420.2376.37M62.01M
2023-02-280.250.4165.80M58.85M
2022-11-092.802.7567.26M62.60M
2022-07-270.051.47108.22M214.78M
2022-04-270.350.4490.06M86.40M
2022-02-090.550.41107.68M106.37M
2021-10-270.900.4397.86M76.04M
2021-07-280.900.29100.81M111.23M
2021-04-280.84-0.0185.52M—
2021-02-030.480.4090.48M74.50M
2020-10-280.280.4288.69M143.27M
2020-07-290.690.3278.95M68.69M
2020-04-290.590.3678.68M70.32M
2020-02-050.420.5075.97M90.44M
2019-10-300.360.3765.75M67.58M
2019-07-240.340.4364.11M81.08M
2019-05-010.310.3655.18M64.08M
2019-02-062.340.6579.86M86.51M
2018-10-310.430.4961.68M70.31M
2018-07-260.490.5567.09M75.32M
2018-04-260.270.5352.38M102.86M
2018-02-080.500.4269.52M58.38M
2017-10-250.220.3148.64M68.48M
2017-07-260.300.2758.56M52.74M
2017-04-270.180.2740.49M72.90M
2017-02-090.220.1943.61M37.65M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency Quarterly.

Safety score 43/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividend history is short. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
2015-09-08$0.252015-09-102015-09-30Quarterly
2015-06-10$0.252015-06-122015-06-30Quarterly
2015-03-10$0.252015-03-122015-03-31Quarterly
2014-11-21$0.252014-11-252014-12-23Quarterly
2014-08-26$0.252014-08-282014-09-18Quarterly

Insider trades

DateInsiderActionSharesPriceValue
2026-08-20Zhen MarianneSell1.13K$21.0023.67K
2026-08-20Basso StephenSell558$21.0011.72K
2026-08-20Raifeld PavelSell1.13K$21.0023.73K
2026-05-20Basso StephenSell559$22.2412.43K
2026-05-20Raifeld PavelSell1.13K$22.2425.13K
2026-05-20Zhen MarianneSell1.13K$22.2425.06K
2026-05-18Linden JosephineBuy9.46K——
2026-05-18Linden JosephineBuy9.17K$21.80199.82K
2026-05-18Linden JosephineBuy5.73K——
2026-05-18Linden JosephineOther0——
2026-05-15Basso StephenBuy1.12K——
2026-05-15Raifeld PavelBuy1.12K——
2026-05-04Raifeld PavelBuy312.50K$22.997.18M
2026-05-04Raifeld PavelBuy126.65K——
2026-05-04DiPaolo MarkBuy9.79K——
2026-05-04DiPaolo MarkBuy10.00K$22.99229.90K
2026-05-04Zhen MarianneBuy12.77K——
2026-05-04Zhen MarianneBuy31.50K$22.99724.18K
2026-05-04Schlesinger Sarah J.Buy9.79K——
2026-05-04Schlesinger Sarah J.Buy10.00K$22.99229.90K
2026-05-04Basso StephenBuy93.75K$22.992.16M
2026-05-04Basso StephenBuy37.99K——
2026-05-04Small Derek ABuy9.79K——
2026-05-04Small Derek ABuy10.00K$22.99229.90K
2026-05-04Haimovitz JulesBuy9.79K——
2026-05-04Haimovitz JulesBuy10.00K$22.99229.90K
2026-02-20Basso StephenSell1.24K$23.3929.10K
2026-02-20Raifeld PavelSell2.99K$23.3969.84K
2026-02-20Zhen MarianneSell2.46K$23.3957.54K
2025-11-20Basso StephenSell237$21.165.01K
2025-11-20Zhen MarianneSell992$21.1620.99K
2025-11-15Basso StephenBuy604——
2025-11-03Basso StephenBuy27.61K$18.11500.00K
2025-11-03Raifeld PavelBuy110.44K$18.112.00M
2025-08-20Basso StephenSell237$19.954.73K
2025-08-20Zhen MarianneSell991$19.9519.77K
2025-05-20Zhen MarianneSell992$18.7818.63K
2025-05-20Basso StephenSell237$18.784.45K
2025-05-19Small Derek ABuy12.08K——
2025-05-19Small Derek ABuy10.00K$18.63186.30K
2025-05-19DiPaolo MarkBuy12.08K——
2025-05-19DiPaolo MarkBuy10.00K$18.63186.30K
2025-05-19Schlesinger Sarah J.Buy12.08K——
2025-05-19Schlesinger Sarah J.Buy10.00K$18.63186.30K
2025-05-19Haimovitz JulesBuy12.08K——
2025-05-19Haimovitz JulesBuy10.00K$18.63186.30K
2025-05-15Raifeld PavelBuy1.86K——
2025-05-15Basso StephenBuy1.35K——
2025-03-14Raifeld PavelBuy243.75K$17.394.24M
2025-03-14Raifeld PavelBuy37.38K$17.39649.99K
2025-03-06DENNER ALEXANDER JSell1.20M$17.5220.96M
2025-03-05DENNER ALEXANDER JSell270.37K$17.634.77M
2025-03-04DENNER ALEXANDER JOther0——
2025-03-04DENNER ALEXANDER JSell151.18K$17.632.67M
2025-02-24Zhen MarianneBuy30.30K$18.08547.82K
2025-02-24Zhen MarianneBuy8.94K$18.08161.60K
2025-02-24Basso StephenBuy100.83K$18.081.82M
2025-02-24Basso StephenBuy10.57K$18.08191.09K
2025-02-20Zhen MarianneSell2.56K$18.0746.35K
2025-02-20Basso StephenSell1.11K$18.0719.99K
2024-11-20Zhen MarianneSell976$19.1518.69K
2024-11-15Basso StephenBuy843——
2024-11-15Zhen MarianneBuy300——
2024-08-20Zhen MarianneSell975$18.4918.03K
2024-06-17Srivastava SapnaBuy13.92K——
2024-06-17Srivastava SapnaBuy10.00K$16.16161.60K
2024-06-17Small Derek ABuy13.92K——
2024-06-17Small Derek ABuy10.00K$16.16161.60K
2024-06-17Schlesinger Sarah J.Buy13.92K——
2024-06-17Schlesinger Sarah J.Buy10.00K$16.16161.60K
2024-06-17Odysseas Kostas DBuy13.92K——
2024-06-17Odysseas Kostas DBuy10.00K$16.16161.60K
2024-06-17Haimovitz JulesBuy13.92K——
2024-06-17Haimovitz JulesBuy10.00K$16.16161.60K
2024-06-17DiPaolo MarkBuy13.92K——
2024-06-17DiPaolo MarkBuy10.00K$16.16161.60K
2024-05-20Ronsheim MatthewSell268$16.134.32K
2024-05-20Zhen MarianneSell976$16.1315.74K
2024-04-29Small Derek ASell833——
2024-04-29Small Derek ASell1.21K——
2024-03-05Basso StephenBuy25.90K$14.88385.38K
2024-03-05Basso StephenBuy12.10K$14.88179.99K
2024-03-05Ronsheim MatthewBuy27.34K$14.88406.79K
2024-03-05Ronsheim MatthewBuy12.77K$14.88189.99K
2024-03-05Zhen MarianneBuy23.02K$14.88342.57K
2024-03-05Zhen MarianneBuy10.75K$14.88159.99K
2024-03-05Raifeld PavelBuy150.00K$20.003.00M
2024-03-05Raifeld PavelBuy100.00K$18.001.80M
2024-03-05Raifeld PavelBuy75.00K$14.881.12M
2024-02-20Ronsheim MatthewSell807$15.8012.75K
2024-02-20Zhen MarianneSell2.86K$15.8045.22K
2024-01-18Ronsheim MatthewBuy60.00K$16.05963.00K
2024-01-18Ronsheim MatthewSell1.60K$16.0525.68K
2024-01-01Ronsheim MatthewSell0——
2024-01-01Ronsheim MatthewSell17.47K——
2024-01-01Ronsheim MatthewSell16.50K$12.98214.17K
2024-01-01Ronsheim MatthewSell16.60K$12.48207.17K
2023-11-20Zhen MarianneSell784$13.6210.68K
2023-11-15Zhen MarianneBuy302——
2023-11-15Zhen MarianneSell5.59K$14.0178.30K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 310, holders +23 vs prior quarter. Ownership 102.18%.

HolderSharesChangeChange %Value
BLACKROCK, INC.11.56M247.36K+2.19%262.42M
DIMENSIONAL FUND ADVISORS LP4.49M57.63K+1.30%102.06M
VANGUARD PORTFOLIO MANAGEMENT LLC4.22M-4.68K-0.11%95.84M
RENAISSANCE TECHNOLOGIES LLC4.04M-19.10K-0.47%91.67M
STATE STREET CORP3.27M207.63K+6.78%74.22M
VANGUARD CAPITAL MANAGEMENT LLC3.16M16.47K+0.52%71.72M
MILLENNIUM MANAGEMENT LLC2.54M261.66K+11.48%57.71M
GEODE CAPITAL MANAGEMENT, LLC2.07M144.99K+7.51%47.13M
SYSTEMATIC FINANCIAL MANAGEMENT LP2.02M-517-0.03%45.96M
BOSTON PARTNERS1.93M209.09K+12.16%43.78M
SARISSA CAPITAL MANAGEMENT LP1.89M-240.35K-11.28%42.94M
BANK OF AMERICA CORP /DE/1.67M47.70K+2.94%37.87M
GOLDMAN SACHS GROUP INC1.62M26.71K+1.68%36.79M
AMERICAN CENTURY COMPANIES INC1.50M-411.98K-21.57%34.02M
MARSHALL WACE, LLP1.45M-50.09K-3.33%33.03M
MORGAN STANLEY1.22M-89.92K-6.86%27.73M
ROYCE & ASSOCIATES LP1.17M111.24K+10.48%26.63M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.15M-12.41K-1.07%26.15M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.1.15M1.15MNew26.15M
TWO SIGMA INVESTMENTS, LP1.03M-451.46K-30.42%23.46M
QUBE RESEARCH & TECHNOLOGIES LTD974.12K188.02K+23.92%22.12M
DEUTSCHE BANK AG\917.96K9.89K+1.09%20.85M
NORTHERN TRUST CORP831.20K56.90K+7.35%18.88M
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN830.37K-61.96K-6.94%18.86M
INVESCO LTD.732.72K-171.56K-18.97%16.64M

Earnings and financials

Innoviva, Inc. (INVA) trades at $21.04, with a market cap of $1.52B and a trailing P/E of 4.29. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
133569000217217000261004000261016000336794000391866000331339000310463000358711000425128000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Innoviva (INVA) Financials: Revenue & Earnings

INVA$21.04+0.10 +0.48%

$1.52B

Market Cap

4.29

P/E

8.69

Forward P/E

70

Score

Price History